{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:40:31Z","timestamp":1791250831955,"version":"4.1.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00702-012-0806-y","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T13:10:50Z","timestamp":1336050650000},"page":"747-757","source":"Crossref","is-referenced-by-count":54,"title":["CSF markers in amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"119","author":[{"given":"Joanna","family":"Tarasiuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Ku\u0142akowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142aw","family":"Drozdowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kornhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Lewczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,4]]},"reference":[{"key":"806_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-4-7","volume":"4","author":"Z Ahmed","year":"2007","unstructured":"Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW (2007) Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation 4:7","journal-title":"J Neuroinflammation"},{"key":"806_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/hmg\/8.2.157","volume":"8","author":"A Al-Chalabi","year":"1999","unstructured":"Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, Shaw CE, Powell JF, Leigh PN (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 8:157\u2013164","journal-title":"Hum Mol Genet"},{"key":"806_CR3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.58.8.1277","volume":"58","author":"G Almer","year":"2002","unstructured":"Almer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, Kostic V, Przedborski S (2002) Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 58:1277\u20131279","journal-title":"Neurology"},{"key":"806_CR4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1531-8249(200004)47:4<524::AID-ANA19>3.0.CO;2-5","volume":"47","author":"K Aoyama","year":"2000","unstructured":"Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, Hayase N, Shiono H, Kobayashi S (2000) Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Ann Neurol 47:524\u2013527","journal-title":"Ann Neurol"},{"key":"806_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0404.1991.tb04656.x","volume":"83","author":"S Apostolski","year":"1991","unstructured":"Apostolski S, Nikoli\u0107 J, Bugarski-Prokopljevi\u0107 C, Mileti\u0107 V, Pavlovi\u0107 S, Filipovi\u0107 S (1991) Serum and CSF immunological findings in ALS. Acta Neurol Scand 83:96\u201398","journal-title":"Acta Neurol Scand"},{"key":"806_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1\u201313","journal-title":"Neurobiol Dis"},{"key":"806_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0006-8993(91)91680-Y","volume":"566","author":"O Bertel","year":"1991","unstructured":"Bertel O, Malessa S, Sluga E, Hornykiewicz O (1991) Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord. Brain Res 566:54\u201360","journal-title":"Brain Res"},{"key":"806_CR8","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1097\/00001756-200011090-00003","volume":"11","author":"W Beuche","year":"2000","unstructured":"Beuche W, Yushchenko M, M\u00e4der M, Maliszewska M, Felgenhauer K, Weber F (2000) Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. NeuroReport 11:3419\u20133422","journal-title":"NeuroReport"},{"key":"806_CR9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005072-199907000-00006","volume":"58","author":"MM Bilak","year":"1999","unstructured":"Bilak MM, Corse AM, Bilak SR, Lehar M, Tombran-Tink J, Kuncl RW (1999) Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol 58:719\u2013728","journal-title":"J Neuropathol Exp Neurol"},{"key":"806_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","volume":"52","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e S, Vande Velde C, Cleveland DW (2006a) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39\u201359","journal-title":"Neuron"},{"key":"806_CR11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW (2006b) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389\u20131392","journal-title":"Science"},{"key":"806_CR12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/A:1022853531855","volume":"28","author":"MC Boll","year":"2003","unstructured":"Boll MC, Alcaraz-Zubeldia M, Montes S, Murillo-Bonilla L, Rios C (2003) Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients. Neurochem Res 28:699\u2013703","journal-title":"Neurochem Res"},{"key":"806_CR13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00109-009-0584-7","volume":"88","author":"P Bossolasco","year":"2010","unstructured":"Bossolasco P, Cova L, Calzarossa C, Servida F, Mencacci NE, Onida F, Polli E, Lambertenghi Deliliers G, Silani V (2010) Metalloproteinase alterations in the bone marrow of ALS patients. J Mol Med (Berl) 88:553\u2013564","journal-title":"J Mol Med (Berl)"},{"key":"806_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","volume":"12","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, Junker A, Tumani H (2006a) Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Mult Scler 12:143\u2013148","journal-title":"Mult Scler"},{"key":"806_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000091436","volume":"21","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, Schottle D, Claus A, Riepe M, Tumani H (2006b) The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 21:291\u2013295","journal-title":"Dement Geriatr Cogn Disord"},{"key":"806_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","volume":"66","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, S\u00fcssmuth SD, Ludolph AC, Tumani H (2006c) Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66:852\u2013856","journal-title":"Neurology"},{"key":"806_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neulet.2006.06.011","volume":"404","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H (2006d) Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett 404:347\u2013351","journal-title":"Neurosci Lett"},{"key":"806_CR18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL, Diseases WFoNRGoMN (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293\u2013299","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"806_CR19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","volume":"27","author":"LI Bruijn","year":"2004","unstructured":"Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723\u2013749","journal-title":"Annu Rev Neurosci"},{"key":"806_CR20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nbd.2005.01.012","volume":"19","author":"NY Calingasan","year":"2005","unstructured":"Calingasan NY, Chen J, Kiaei M, Beal MF (2005) Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol Dis 19:340\u2013347","journal-title":"Neurobiol Dis"},{"key":"806_CR21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2008.06.025","volume":"158","author":"E Candelario-Jalil","year":"2009","unstructured":"Candelario-Jalil E, Yang Y, Rosenberg GA (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158:983\u2013994","journal-title":"Neuroscience"},{"key":"806_CR22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/82122","volume":"6","author":"DW Cleveland","year":"2000","unstructured":"Cleveland DW, Liu J (2000) Oxidation versus aggregation\u2014how do SOD1 mutants cause ALS? Nat Med 6:1320\u20131321","journal-title":"Nat Med"},{"key":"806_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2003.12.009","volume":"187","author":"C Consilvio","year":"2004","unstructured":"Consilvio C, Vincent AM, Feldman EL (2004) Neuroinflammation, COX-2, and ALS\u2013a dual role? Exp Neurol 187:1\u201310","journal-title":"Exp Neurol"},{"key":"806_CR24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/002215540004800713","volume":"48","author":"R Daniel","year":"2000","unstructured":"Daniel R, He Z, Carmichael KP, Halper J, Bateman A (2000) Cellular localization of gene expression for progranulin. J Histochem Cytochem 48:999\u20131009","journal-title":"J Histochem Cytochem"},{"key":"806_CR25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.neurobiolaging.2009.06.006","volume":"32","author":"R Bo Del","year":"2011","unstructured":"Del Bo R, Corti S, Santoro D, Ghione I, Fenoglio C, Ghezzi S, Ranieri M, Galimberti D, Mancuso M, Siciliano G, Briani C, Murri L, Scarpini E, Schymick JC, Traynor BJ, Bresolin N, Comi GP (2011) No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort. Neurobiol Aging 32:1157\u20131158","journal-title":"Neurobiol Aging"},{"key":"806_CR26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2004.09.015","volume":"159","author":"M Demestre","year":"2005","unstructured":"Demestre M, Parkin-Smith G, Petzold A, Pullen AH (2005) The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol 159:146\u2013154","journal-title":"J Neuroimmunol"},{"key":"806_CR27","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1212\/01.WNL.0000129913.44351.A3","volume":"62","author":"D Devos","year":"2004","unstructured":"Devos D, Moreau C, Lassalle P, Perez T, De Seze J, Brunaud-Danel V, Dest\u00e9e A, Tonnel AB, Just N (2004) Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology 62:2127\u20132129","journal-title":"Neurology"},{"key":"806_CR28","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","volume":"47","author":"A Doble","year":"1996","unstructured":"Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47:S233\u2013S241","journal-title":"Neurology"},{"key":"806_CR29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"R Donato","year":"2001","unstructured":"Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33:637\u2013668","journal-title":"Int J Biochem Cell Biol"},{"key":"806_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/400_020","volume":"43","author":"B Engelhardt","year":"2006","unstructured":"Engelhardt B (2006) Regulation of immune cell entry into the central nervous system. Results Probl Cell Differ 43:259\u2013280","journal-title":"Results Probl Cell Differ"},{"key":"806_CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jns.2010.04.005","volume":"294","author":"L Fang","year":"2010","unstructured":"Fang L, Teuchert M, Huber-Abel F, Schattauer D, Hendrich C, Dorst J, Zettlmeissel H, Wlaschek M, Scharffetter-Kochanek K, Kapfer T, Tumani H, Ludolph AC, Brettschneider J (2010) MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J Neurol Sci 294:51\u201356","journal-title":"J Neurol Sci"},{"key":"806_CR32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/17482960801984358","volume":"9","author":"K Frutiger","year":"2008","unstructured":"Frutiger K, Lukas TJ, Gorrie G, Ajroud-Driss S, Siddique T (2008) Gender difference in levels of Cu\/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9:184\u2013187","journal-title":"Amyotroph Lateral Scler"},{"key":"806_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(98)00088-4","volume":"158","author":"K Fujita","year":"1998","unstructured":"Fujita K, Honda M, Hayashi R, Ogawa K, Ando M, Yamauchi M, Nagata Y (1998) Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss. J Neurol Sci 158:53\u201357","journal-title":"J Neurol Sci"},{"key":"806_CR34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","volume":"117","author":"J Ganesalingam","year":"2011","unstructured":"Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R (2011) Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem 117:528\u2013537","journal-title":"J Neurochem"},{"key":"806_CR35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","volume":"1157","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR (2007a) Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 1157:126\u2013137","journal-title":"Brain Res"},{"key":"806_CR36","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1371\/journal.pone.0001205","volume":"2","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, Sanberg PR (2007b) Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE 2:e1205","journal-title":"PLoS ONE"},{"key":"806_CR37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/17482960802160990","volume":"9","author":"S Garbuzova-Davis","year":"2008","unstructured":"Garbuzova-Davis S, Saporta S, Sanberg PR (2008) Implications of blood-brain barrier disruption in ALS. Amyotroph Lateral Scler 9:375\u2013376","journal-title":"Amyotroph Lateral Scler"},{"key":"806_CR38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","volume":"1398","author":"S Garbuzova-Davis","year":"2011","unstructured":"Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, Sanberg PR (2011) Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res 1398:113\u2013125","journal-title":"Brain Res"},{"key":"806_CR39","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2741\/1883","volume":"11","author":"Y Gasche","year":"2006","unstructured":"Gasche Y, Soccal PM, Kanemitsu M, Copin JC (2006) Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 11:1289\u20131301","journal-title":"Front Biosci"},{"key":"806_CR40","first-page":"617","volume":"150","author":"AR Glabinski","year":"1997","unstructured":"Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM (1997) Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150:617\u2013630","journal-title":"Am J Pathol"},{"key":"806_CR41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","volume":"342","author":"IL Goldknopf","year":"2006","unstructured":"Goldknopf IL, Sheta EA, Bryson J, Folsom B, Wilson C, Duty J, Yen AA, Appel SH (2006) Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson\u2019s disease. Biochem Biophys Res Commun 342:1034\u20131039","journal-title":"Biochem Biophys Res Commun"},{"key":"806_CR42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14660820410020286","volume":"5","author":"MC Graves","year":"2004","unstructured":"Graves MC, Fiala M, Dinglasan LA, Liu NQ, Sayre J, Chiappelli F, van Kooten C, Vinters HV (2004) Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord 5:213\u2013219","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"806_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002093-199903000-00002","volume":"13","author":"H Hampel","year":"1999","unstructured":"Hampel H, K\u00f6tter HU, Padberg F, K\u00f6rschenhausen DA, M\u00f6ller HJ (1999) Oligoclonal bands and blood\u2013cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis. Alzheimer Dis Assoc Disord 13:9\u201319","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Pt 3","key":"806_CR44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/118.3.707","volume":"118","author":"LJ Haverkamp","year":"1995","unstructured":"Haverkamp LJ, Appel V, Appel SH (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 118(Pt 3):707\u2013719","journal-title":"Brain"},{"key":"806_CR45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel JS, Engelhardt JI, Sikl\u00f3s L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH (2004) Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55:221\u2013235","journal-title":"Ann Neurol"},{"key":"806_CR46","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/WNL.0b013e3181a41228","volume":"72","author":"JS Henkel","year":"2009","unstructured":"Henkel JS, Beers DR, Wen S, Bowser R, Appel SH (2009) Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology 72:1614\u20131616","journal-title":"Neurology"},{"key":"806_CR47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1179\/016164105X18430","volume":"27","author":"Y Ihara","year":"2005","unstructured":"Ihara Y, Nobukuni K, Takata H, Hayabara T (2005) Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. Neurol Res 27:105\u2013108","journal-title":"Neurol Res"},{"key":"806_CR48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clineuro.2003.12.007","volume":"106","author":"J I\u0142zecka","year":"2004","unstructured":"I\u0142zecka J (2004) Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. Clin Neurol Neurosurg 106:289\u2013293","journal-title":"Clin Neurol Neurosurg"},{"key":"806_CR49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00415-004-0296-4","volume":"251","author":"JC Janssen","year":"2004","unstructured":"Janssen JC, Godbolt AK, Ioannidis P, Thompson EJ, Rossor MN (2004) The prevalence of oligoclonal bands in the CSF of patients with primary neurodegenerative dementia. J Neurol 251:184\u2013188","journal-title":"J Neurol"},{"key":"806_CR50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/awh704","volume":"129","author":"PA Jonsson","year":"2006","unstructured":"Jonsson PA, Graffmo KS, Andersen PM, Br\u00e4nnstr\u00f6m T, Lindberg M, Oliveberg M, Marklund SL (2006) Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129:451\u2013464","journal-title":"Brain"},{"key":"806_CR51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","volume":"117","author":"T Kasai","year":"2009","unstructured":"Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, Mann DM, Allsop D, Nakagawa M (2009) Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol 117:55\u201362","journal-title":"Acta Neuropathol"},{"key":"806_CR52","first-page":"691","volume":"140","author":"T Kawamata","year":"1992","unstructured":"Kawamata T, Akiyama H, Yamada T, McGeer PL (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140:691\u2013707","journal-title":"Am J Pathol"},{"key":"806_CR53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/REVNEURO.1998.9.2.105","volume":"9","author":"JN Keller","year":"1998","unstructured":"Keller JN, Mattson MP (1998) Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 9:105\u2013116","journal-title":"Rev Neurosci"},{"key":"806_CR54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1179\/135100005X70242","volume":"10","author":"AN Koki\u0107","year":"2005","unstructured":"Koki\u0107 AN, Stevi\u0107 Z, Stojanovi\u0107 S, Blagojevi\u0107 DP, Jones DR, Pavlovi\u0107 S, Niketi\u0107 V, Apostolski S, Spasi\u0107 MB (2005) Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Redox Rep 10:265\u2013270","journal-title":"Redox Rep"},{"key":"806_CR55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1471-4159.2002.00813.x","volume":"81","author":"RW Kuncl","year":"2002","unstructured":"Kuncl RW, Bilak MM, Bilak SR, Corse AM, Royal W, Becerra SP (2002) Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J Neurochem 81:178\u2013184","journal-title":"J Neurochem"},{"key":"806_CR56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cccn.2005.07.008","volume":"364","author":"M Ku\u017ama","year":"2006","unstructured":"Ku\u017ama M, Jamrozik Z, Bara\u0144czyk-Ku\u017ama A (2006) Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis. Clin Chim Acta 364:217\u2013221","journal-title":"Clin Chim Acta"},{"key":"806_CR57","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","volume":"347","author":"L Lacomblez","year":"1996","unstructured":"Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II. Lancet 347:1425\u20131431","journal-title":"Lancet"},{"key":"806_CR58","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jmg.2008.058222","volume":"46","author":"D Lambrechts","year":"2009","unstructured":"Lambrechts D, Poesen K, Fern\u00e1ndez-Santiago R, Al-Chalabi A, Del Bo R, Van Vught PW, Khan S, Marklund SL, Brockington A, van Marion I, Anneser J, Shaw C, Ludolph AC, Leigh NP, Comi GP, Gasser T, Shaw PJ, Morrison KE, Andersen PM, Van den Berg LH, Thijs V, Siddique T, Robberecht W, Carmeliet P (2009) Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet 46:840\u2013846","journal-title":"J Med Genet"},{"issue":"Suppl 4","key":"806_CR59","first-page":"iv32","volume":"74","author":"PN Leigh","year":"2003","unstructured":"Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, Lyall R, Moxham J, Mustfa N, Rio A, Shaw C, Willey E, Team KsMCaR (2003) The management of motor neurone disease. J Neurol Neurosurg Psychiatry 74(Suppl 4):iv32\u2013iv47","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"806_CR60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00313720","volume":"231","author":"A Leonardi","year":"1984","unstructured":"Leonardi A, Abbruzzese G, Arata L, Cocito L, Vische M (1984) Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis. J Neurol 231:75\u201378","journal-title":"J Neurol"},{"key":"806_CR61","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.51.6.778","volume":"51","author":"TM Li","year":"1988","unstructured":"Li TM, Alberman E, Swash M (1988) Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 51:778\u2013784","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"806_CR62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mus.10191","volume":"26","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459\u2013470","journal-title":"Muscle Nerve"},{"key":"806_CR63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(98)01001-5","volume":"261","author":"A Migheli","year":"1999","unstructured":"Migheli A, Cordera S, Bendotti C, Atzori C, Piva R, Schiffer D (1999) S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett 261:25\u201328","journal-title":"Neurosci Lett"},{"key":"806_CR64","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(07)60944-1","volume":"369","author":"JD Mitchell","year":"2007","unstructured":"Mitchell JD, Borasio GD (2007) Amyotrophic lateral sclerosis. Lancet 369:2031\u20132041","journal-title":"Lancet"},{"key":"806_CR65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","volume":"72","author":"RM Mitchell","year":"2009","unstructured":"Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, Connor JR (2009) A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72:14\u201319","journal-title":"Neurology"},{"key":"806_CR66","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jnr.22594","volume":"89","author":"K Miyazaki","year":"2011","unstructured":"Miyazaki K, Ohta Y, Nagai M, Morimoto N, Kurata T, Takehisa Y, Ikeda Y, Matsuura T, Abe K (2011) Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res 89:718\u2013728","journal-title":"J Neurosci Res"},{"key":"806_CR67","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/01.wnl.0000188907.97339.76","volume":"65","author":"C Moreau","year":"2005","unstructured":"Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Dest\u00e9e A, Tonnel AB, Lassalle P, Just N (2005) Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology 65:1958\u20131960","journal-title":"Neurology"},{"key":"806_CR68","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/10408360490504934","volume":"41","author":"M Mussap","year":"2004","unstructured":"Mussap M, Plebani M (2004) Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 41:467\u2013550","journal-title":"Crit Rev Clin Lab Sci"},{"key":"806_CR69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2005.10.063","volume":"1066","author":"A Nagai","year":"2005","unstructured":"Nagai A, Ryu JK, Terashima M, Tanigawa Y, Wakabayashi K, McLarnon JG, Kobayashi S, Masuda J, Kim SU (2005) Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B. Brain Res 1066:120\u2013128","journal-title":"Brain Res"},{"key":"806_CR70","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/mus.20768","volume":"35","author":"C Neusch","year":"2007","unstructured":"Neusch C, B\u00e4hr M, Schneider-Gold C (2007) Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve 35:712\u2013724","journal-title":"Muscle Nerve"},{"key":"806_CR71","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","volume":"1301","author":"C Nicaise","year":"2009","unstructured":"Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A, Pochet R (2009a) Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 1301:152\u2013162","journal-title":"Brain Res"},{"key":"806_CR72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ar.20838","volume":"292","author":"C Nicaise","year":"2009","unstructured":"Nicaise C, Soyfoo MS, Authelet M, De Decker R, Bataveljic D, Delporte C, Pochet R (2009b) Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken) 292:207\u2013213","journal-title":"Anat Rec (Hoboken)"},{"key":"806_CR73","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0404.1999.tb00387.x","volume":"100","author":"I Niebroj-Dobosz","year":"1999","unstructured":"Niebroj-Dobosz I, Jamrozik Z, Janik P, Hausmanowa-Petrusewicz I, Kwieci\u0144ski H (1999) Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 100:238\u2013243","journal-title":"Acta Neurol Scand"},{"key":"806_CR74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","volume":"17","author":"I Niebroj-Dobosz","year":"2010","unstructured":"Niebroj-Dobosz I, Janik P, Soko\u0142owska B, Kwiecinski H (2010) Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol 17:226\u2013231","journal-title":"Eur J Neurol"},{"key":"806_CR75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","volume":"987","author":"N Norgren","year":"2003","unstructured":"Norgren N, Rosengren L, Stigbrand T (2003) Elevated neurofilament levels in neurological diseases. Brain Res 987:25\u201331","journal-title":"Brain Res"},{"key":"806_CR76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/17482968.2010.541263","volume":"12","author":"Y Noto","year":"2011","unstructured":"Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, Mori M, Uchiyama T, Isose S, Nasu S, Sekiguchi Y, Fujimaki Y, Kasai T, Tokuda T, Nakagawa M, Kuwabara S (2011) Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Amyotroph Lateral Scler 12:140\u2013143","journal-title":"Amyotroph Lateral Scler"},{"key":"806_CR77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000008178","volume":"43","author":"S Ono","year":"2000","unstructured":"Ono S, Imai T, Shimizu N, Nagao K (2000) Increased expression of laminin 1 in the skin of amyotrophic lateral sclerosis. Eur Neurol 43:215\u2013220","journal-title":"Eur Neurol"},{"key":"806_CR78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(97)00947-6","volume":"240","author":"M Otto","year":"1998","unstructured":"Otto M, Bahn E, Wiltfang J, Boekhoff I, Beuche W (1998) Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosis. Neurosci Lett 240:171\u2013173","journal-title":"Neurosci Lett"},{"key":"806_CR79","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/13550289909021285","volume":"5","author":"WM Pardridge","year":"1999","unstructured":"Pardridge WM (1999) Blood-brain barrier biology and methodology. J Neurovirol 5:556\u2013569","journal-title":"J Neurovirol"},{"key":"806_CR80","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","volume":"7","author":"P Pasinelli","year":"2006","unstructured":"Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7:710\u2013723","journal-title":"Nat Rev Neurosci"},{"key":"806_CR81","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/01.wnl.0000203129.82104.07","volume":"66","author":"GM Pasinetti","year":"2006","unstructured":"Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L (2006) Identification of potential CSF biomarkers in ALS. Neurology 66:1218\u20131222","journal-title":"Neurology"},{"key":"806_CR82","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/NEN.0b013e3181fc9aea","volume":"69","author":"T Philips","year":"2010","unstructured":"Philips T, De Muynck L, Thu HN, Weynants B, Vanacker P, Dhondt J, Sleegers K, Schelhaas HJ, Verbeek M, Vandenberghe R, Sciot R, Van Broeckhoven C, Lambrechts D, Van Leuven F, Van Den Bosch L, Robberecht W, Van Damme P (2010) Microglial upregulation of progranulin as a marker of motor neuron degeneration. J Neuropathol Exp Neurol 69:1191\u20131200","journal-title":"J Neuropathol Exp Neurol"},{"key":"806_CR83","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.2004.00223.x","volume":"109","author":"T Pirttil\u00e4","year":"2004","unstructured":"Pirttil\u00e4 T, Vanhatalo S, Turpeinen U, Riikonen R (2004) Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS. Acta Neurol Scand 109:337\u2013341","journal-title":"Acta Neurol Scand"},{"key":"806_CR84","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.2005.03478.x","volume":"95","author":"S Ranganathan","year":"2005","unstructured":"Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH, Bowser R (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 95:1461\u20131471","journal-title":"J Neurochem"},{"key":"806_CR85","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.coi.2006.09.005","volume":"18","author":"NM Rebenko-Moll","year":"2006","unstructured":"Rebenko-Moll NM, Liu L, Cardona A, Ransohoff RM (2006) Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr Opin Immunol 18:683\u2013689","journal-title":"Curr Opin Immunol"},{"key":"806_CR86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/135245859800400304","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H, Ungefehr S, Jacobi C (1998) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111\u2013117","journal-title":"Mult Scler"},{"key":"806_CR87","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.43.7.1316","volume":"43","author":"SP Ringel","year":"1993","unstructured":"Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, Petajan JH, Smith SA, Roelofs RI, Ziter F (1993) The natural history of amyotrophic lateral sclerosis. Neurology 43:1316\u20131322","journal-title":"Neurology"},{"key":"806_CR88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/364362c0","volume":"364","author":"DR Rosen","year":"1993","unstructured":"Rosen DR (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364:362","journal-title":"Nature"},{"key":"806_CR89","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkels\u00f8 C (1996) Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 67:2013\u20132018","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"806_CR90","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein JD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(Suppl 1):S3\u2013S9","journal-title":"Ann Neurol"},{"key":"806_CR91","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688\u20131700","journal-title":"N Engl J Med"},{"key":"806_CR92","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2741\/2111","volume":"12","author":"Q Ruan","year":"2007","unstructured":"Ruan Q, Johnson GV (2007) Transglutaminase 2 in neurodegenerative disorders. Front Biosci 12:891\u2013904","journal-title":"Front Biosci"},{"key":"806_CR93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3171\/jns.1988.69.2.0155","volume":"69","author":"JT Rutka","year":"1988","unstructured":"Rutka JT, Apodaca G, Stern R, Rosenblum M (1988) The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69:155\u2013170","journal-title":"J Neurosurg"},{"key":"806_CR94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2003.12.012","volume":"45","author":"H Ryberg","year":"2004","unstructured":"Ryberg H, S\u00f6derling AS, Davidsson P, Blennow K, Caidahl K, Persson LI (2004) Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer\u2019s disease. Neurochem Int 45:57\u201362","journal-title":"Neurochem Int"},{"key":"806_CR95","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2009.07.011","volume":"215","author":"IA Saleh","year":"2009","unstructured":"Saleh IA, Zesiewicz T, Xie Y, Sullivan KL, Miller AM, Kuzmin-Nichols N, Sanberg PR, Garbuzova-Davis S (2009) Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression. J Neuroimmunol 215:96\u2013101","journal-title":"J Neuroimmunol"},{"issue":"Spec No. 2","key":"806_CR96","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1093\/hmg\/ddm215","volume":"16","author":"JC Schymick","year":"2007","unstructured":"Schymick JC, Talbot K, Traynor BJ (2007) Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 16(Spec No. 2):R233\u2013R242","journal-title":"Hum Mol Genet"},{"key":"806_CR97","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-510X(97)00228-1","volume":"154","author":"T Sekizawa","year":"1998","unstructured":"Sekizawa T, Openshaw H, Ohbo K, Sugamura K, Itoyama Y, Niland JC (1998) Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci 154:194\u2013199","journal-title":"J Neurol Sci"},{"key":"806_CR98","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612053507837","volume":"11","author":"HS Sharma","year":"2005","unstructured":"Sharma HS (2005) Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr Pharm Des 11:1353\u20131389","journal-title":"Curr Pharm Des"},{"key":"806_CR99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-8993(01)02926-2","volume":"917","author":"N Shibata","year":"2001","unstructured":"Shibata N, Nagai R, Uchida K, Horiuchi S, Yamada S, Hirano A, Kawaguchi M, Yamamoto T, Sasaki S, Kobayashi M (2001) Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 917:97\u2013104","journal-title":"Brain Res"},{"key":"806_CR100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.2006.103564","volume":"78","author":"CL Shoesmith","year":"2007","unstructured":"Shoesmith CL, Findlater K, Rowe A, Strong MJ (2007) Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 78:629\u2013631","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Spec No","key":"806_CR101","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/5.Supplement_1.1465","volume":"5","author":"T Siddique","year":"1996","unstructured":"Siddique T, Deng HX (1996) Genetics of amyotrophic lateral sclerosis. Hum Mol Genet 5(Spec No):1465\u20131470","journal-title":"Hum Mol Genet"},{"key":"806_CR102","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00002281-200311000-00008","volume":"15","author":"EP Simpson","year":"2003","unstructured":"Simpson EP, Yen AA, Appel SH (2003) Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol 15:730\u2013736","journal-title":"Curr Opin Rheumatol"},{"key":"806_CR103","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","volume":"62","author":"EP Simpson","year":"2004","unstructured":"Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH (2004) Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 62:1758\u20131765","journal-title":"Neurology"},{"key":"806_CR104","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.54.10.1960","volume":"54","author":"M Sj\u00f6gren","year":"2000","unstructured":"Sj\u00f6gren M, Rosengren L, Minthon L, Davidsson P, Blennow K, Wallin A (2000) Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Neurology 54:1960\u20131964","journal-title":"Neurology"},{"key":"806_CR105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000289191.54852.75","volume":"71","author":"K Sleegers","year":"2008","unstructured":"Sleegers K, Brouwers N, Maurer-Stroh S, van Es MA, Van Damme P, van Vught PW, van der Zee J, Serneels S, De Pooter T, Van den Broeck M, Cruts M, Schymkowitz J, De Jonghe P, Rousseau F, van den Berg LH, Robberecht W, Van Broeckhoven C (2008) Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 71:253\u2013259","journal-title":"Neurology"},{"key":"806_CR106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(01)00661-X","volume":"193","author":"O Spreux-Varoquaux","year":"2002","unstructured":"Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, Marouan A, Dib M, Meininger V (2002) Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 193:73\u201378","journal-title":"J Neurol Sci"},{"key":"806_CR107","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668\u20131672","journal-title":"Science"},{"key":"806_CR108","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/14660820310011250","volume":"4","author":"M Strong","year":"2003","unstructured":"Strong M, Rosenfeld J (2003) Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord 4:136\u2013143","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"806_CR109","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.jnen.0000173889.71434.ea","volume":"64","author":"MJ Strong","year":"2005","unstructured":"Strong MJ, Kesavapany S, Pant HC (2005) The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol 64:649\u2013664","journal-title":"J Neuropathol Exp Neurol"},{"key":"806_CR110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2003.09.018","volume":"353","author":"SD S\u00fcssmuth","year":"2003","unstructured":"S\u00fcssmuth SD, Tumani H, Ecker D, Ludolph AC (2003) Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Neurosci Lett 353:57\u201360","journal-title":"Neurosci Lett"},{"key":"806_CR111","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/WNL.0b013e3181d5dc3b","volume":"74","author":"SD S\u00fcssmuth","year":"2010","unstructured":"S\u00fcssmuth SD, Sperfeld AD, Hinz A, Brettschneider J, Endruhn S, Ludolph AC, Tumani H (2010) CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology 74:982\u2013987","journal-title":"Neurology"},{"key":"806_CR112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jnnp.51.2.165","volume":"51","author":"M Swash","year":"1988","unstructured":"Swash M, Ingram D (1988) Preclinical and subclinical events in motor neuron disease. J Neurol Neurosurg Psychiatry 51:165\u2013168","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"806_CR113","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-007-0206-9","volume":"113","author":"CF Tan","year":"2007","unstructured":"Tan CF, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A, Nishizawa M, Kakita A, Takahashi H (2007) TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 113:535\u2013542","journal-title":"Acta Neuropathol"},{"key":"806_CR114","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000232025.84238.e1","volume":"65","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, Tateishi T, Ohyagi Y, Kira J (2006) Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 65:816\u2013825","journal-title":"J Neuropathol Exp Neurol"},{"key":"806_CR115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0304-3940(98)00986-0","volume":"260","author":"H Tohgi","year":"1999","unstructured":"Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C (1999) Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci Lett 260:204\u2013206","journal-title":"Neurosci Lett"},{"key":"806_CR116","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archneur.57.1.109","volume":"57","author":"BJ Traynor","year":"2000","unstructured":"Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O (2000) Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 57:109\u2013113","journal-title":"Arch Neurol"},{"key":"806_CR117","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jnnp.57.7.859","volume":"57","author":"Y Tsuboi","year":"1994","unstructured":"Tsuboi Y, Yamada T (1994) Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 57:859\u2013861","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"806_CR118","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archneur.56.10.1241","volume":"56","author":"H Tumani","year":"1999","unstructured":"Tumani H, Shen G, Peter JB, Br\u00fcck W (1999) Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease? Arch Neurol 56:1241\u20131246","journal-title":"Arch Neurol"},{"key":"806_CR119","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737159.8.4.479","volume":"8","author":"H Tumani","year":"2008","unstructured":"Tumani H, Teunissen C, S\u00fcssmuth S, Otto M, Ludolph AC, Brettschneider J (2008) Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. Expert Rev Mol Diagn 8:479\u2013494","journal-title":"Expert Rev Mol Diagn"},{"key":"806_CR120","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","volume":"1762","author":"L Bosch Van Den","year":"2006","unstructured":"Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W (2006) The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1068\u20131082","journal-title":"Biochim Biophys Acta"},{"key":"806_CR121","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/humu.9484","volume":"28","author":"J Zee van der","year":"2007","unstructured":"van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, Camuzat A, Brouwers N, Vandenberghe R, Sleegers K, Hannequin D, Dermaut B, Schymkowitz J, Campion D, Santens P, Martin JJ, Lacomblez L, De Pooter T, Peeters K, Mattheijssens M, Vercelletto M, Van den Broeck M, Cruts M, De Deyn PP, Rousseau F, Brice A, Van Broeckhoven C (2007) Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat 28:416","journal-title":"Hum Mutat"},{"key":"806_CR122","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2010.12.004","volume":"130","author":"RL Vangilder","year":"2011","unstructured":"Vangilder RL, Rosen CL, Barr TL, Huber JD (2011) Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol Ther 130:239\u2013247","journal-title":"Pharmacol Ther"},{"key":"806_CR123","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2004.07.084","volume":"1025","author":"R Bernhardi von","year":"2004","unstructured":"von Bernhardi R, Eugen\u00edn J (2004) Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 1025:186\u2013193","journal-title":"Brain Res"},{"key":"806_CR124","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0173(03)00177-2","volume":"42","author":"AW Vorbrodt","year":"2003","unstructured":"Vorbrodt AW, Dobrogowska DH (2003) Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist\u2019s view. Brain Res Brain Res Rev 42:221\u2013242","journal-title":"Brain Res Brain Res Rev"},{"key":"806_CR125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s004010051063","volume":"98","author":"M Wada","year":"1999","unstructured":"Wada M, Uchihara T, Nakamura A, Oyanagi K (1999) Bunina bodies in amyotrophic lateral sclerosis on Guam: a histochemical, immunohistochemical and ultrastructural investigation. Acta Neuropathol 98:150\u2013156","journal-title":"Acta Neuropathol"},{"key":"806_CR126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2003.08.042","volume":"144","author":"H Wilms","year":"2003","unstructured":"Wilms H, Sievers J, Dengler R, Bufler J, Deuschl G, Lucius R (2003) Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J Neuroimmunol 144:139\u2013142","journal-title":"J Neuroimmunol"},{"key":"806_CR127","doi-asserted-by":"crossref","first-page":"e15133","DOI":"10.1371\/journal.pone.0015133","volume":"5","author":"ME Wilson","year":"2010","unstructured":"Wilson ME, Boumaza I, Lacomis D, Bowser R (2010) Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. PLoS ONE 5:e15133","journal-title":"PLoS ONE"},{"key":"806_CR128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(05)70042-9","volume":"4","author":"JM Winhammar","year":"2005","unstructured":"Winhammar JM, Rowe DB, Henderson RD, Kiernan MC (2005) Assessment of disease progression in motor neuron disease. Lancet Neurol 4:229\u2013238","journal-title":"Lancet Neurol"},{"key":"806_CR129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251\u2013253","journal-title":"Nat Neurosci"},{"key":"806_CR130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","volume":"6","author":"Y Yiangou","year":"2006","unstructured":"Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C, Banati RR, Anand P (2006) COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6:12","journal-title":"BMC Neurol"},{"key":"806_CR131","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2169\/internalmedicine.38.133","volume":"38","author":"Y Yoshida","year":"1999","unstructured":"Yoshida Y, Une F, Utatsu Y, Nomoto M, Furukawa Y, Maruyama Y, Machigashira N, Matsuzaki T, Osame M (1999) Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders. Intern Med 38:133\u2013139","journal-title":"Intern Med"},{"key":"806_CR132","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-4159.2011.07177.x","volume":"117","author":"P Zetterstr\u00f6m","year":"2011","unstructured":"Zetterstr\u00f6m P, Andersen PM, Br\u00e4nnstr\u00f6m T, Marklund SL (2011) Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J Neurochem 117:91\u201399","journal-title":"J Neurochem"},{"key":"806_CR133","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2004.10.009","volume":"159","author":"R Zhang","year":"2005","unstructured":"Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, Jin X, Reis J, Narvaez A, McGrath MS (2005) Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 159:215\u2013224","journal-title":"J Neuroimmunol"},{"key":"806_CR134","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/jnen\/63.9.964","volume":"63","author":"W Zhao","year":"2004","unstructured":"Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, Simpson EP, Yen AA, Xiao Q, Appel SH (2004) Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 63:964\u2013977","journal-title":"J Neuropathol Exp Neurol"},{"key":"806_CR135","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nn2073","volume":"11","author":"Z Zhong","year":"2008","unstructured":"Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O\u2019Banion MK, Stojanovic K, Sagare A, Boillee S, Cleveland DW, Zlokovic BV (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11:420\u2013422","journal-title":"Nat Neurosci"},{"key":"806_CR136","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2006.06.027","volume":"250","author":"S Zoccolella","year":"2006","unstructured":"Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P, Lepore V, Serlenga L, Logroscino G, S registry (2006) Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci 250:45\u201349","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0806-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-012-0806-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0806-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T06:02:09Z","timestamp":1561701729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0806-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,4]]},"references-count":136,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0806-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,4]]}}}